|
⚲
|
| Pacific Beach Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001422702 |
| Sale | 2010-02-09 ($5.5 M Offered, $3.3 M Sold) |
| Fund | |
| Phone | 8587318899 |
| Address | c/o Paramount Biosciences, LLC New York, 10019 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Mark Lotz | |
| Matthew Wikler | |
| James Rock | |
| Jay Lobell |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Catamount Absolute Return Fund LP
✚
|
0.0 | |
|
Caterpillar Financial Services Corp
✚
|
0.0 | |
|
Aon Hewitt Offshore Fund of Hedge Funds Ltd.
✚
|
0.0 | |
|
Allocations Funds LLC - Series 12
✚
|
0.0 | |
|
AP Fund I, a series of Accomplice SPV Funds, LP
✚
|
0.0 | |
|
AP Fund I, a series of Capital Factory, LP
✚
|
0.0 | |
|
AP Fund I, a series of DataPower Ventures Funds AL, LP
✚
|
0.0 | |
|
AP Fund I, a series of Permit RH, LP
✚
|
0.0 | |
|
AP Fund I, a series of Veritas Innovations, LP
✚
|
0.0 | |
|
Allocations Funds LLC - Series 11
✚
|
0.0 |